Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.390
-0.080 (-5.44%)
Aug 22, 2025, 3:41 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.89 billion as of August 22, 2025. Its market cap has increased by 90.80% in one year.
Market Cap
2.89B
Enterprise Value
3.76B
Revenue
1.98B
Ranking
n/a
PE Ratio
470.99
Stock Price
1.39
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.89B, a decrease of -56.97%. That is a compound annual growth rate of -12.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 2.89B | -19.66% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | 8.66B | -2.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.89B |
| Hansoh Pharmaceutical Group Company | 217.86B |
| JD Health International | 203.69B |
| Innovent Biologics | 170.08B |
| Akeso | 150.79B |
| Sino Biopharmaceutical | 138.07B |
| WuXi Biologics | 124.64B |
| CSPC Pharmaceutical Group | 119.93B |